Sipai Health Technology (SEHK:314) Reports Full Year 2024 Earnings
Sipai Health Technology, a company operating in the medical technology and health management sector within the People’s Republic of China, recently released its full-year 2024 financial results. The report indicates a challenging year for the company, with both revenue and profitability taking a hit.
Key Financial Highlights
- Revenue: CN¥4.57 billion, representing a 3.1% decrease compared to the CN¥4.71 billion reported in fiscal year 2023.
- Net Loss: The company’s net loss widened to CN¥323.7 million, a 27% increase from the CN¥254.8 million loss in the previous fiscal year.
- Loss Per Share: The loss per share further deteriorated to CN¥0.51, compared to a loss of CN¥0.40 in the prior year.
The provided data reflects the financial performance of Sipai Health Technology for the trailing 12 months.
It’s worth noting that Sipai Health Technology shares have seen an increase of 21% in the week leading up to the report. Further analysis of the balance sheet is important to gauge the company’s financial health.
Disclaimer: This analysis is based on historical data and analyst forecasts and does not constitute financial advice.
